The capital will help turn early-stage university ideas into successful spinouts, having already backed a Car T-based immuno-oncological therapy for multiple myeloma.
University of Utah has launched the University of Utah Seed Fund with up to $1m in capital to support early-stage university technologies capable of luring external funding and achieving commercialisation.
The Center for Technology and Venture Commercialization (TVC) will oversee the fund, which is expected to help researchers cross the so-called valley of death between forming a business and generating revenues.
The University of Utah Seed Fund’s first investment is a Car T-based therapy for treating a blood-borne cancer called…
